Breaking News Instant updates and real-time market news.

ASXC

Asensus Surgical

/

+

17:02
03/18/22
03/18
17:02
03/18/22
17:02

Asensus Surgical files $150M mixed securities shelf

OTHER BREAKING NEWS FROM THE FLY

Initiation
Vidrala initiated with an Underperform at Jefferies » 05:20
12/01/22
12/01
05:20
12/01/22
05:20
VDRFF

Vidrala

$109.13 /

+ (+0.00%)

Jefferies analyst Michele…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VDRFF Vidrala
$109.13 /

+ (+0.00%)

11/23/22 Oddo BHF
Vidrala downgraded to Neutral from Outperform at Oddo BHF
10/20/22 Berenberg
Vidrala price target lowered to EUR 84 from EUR 91 at Berenberg
10/11/22 Citi
Vidrala downgraded to Sell from Neutral at Citi
07/22/22 Berenberg
Vidrala price target lowered to EUR 91 from EUR 104 at Berenberg
Hot Stocks
Li Auto delivers 15,034 vehicles in November, up 11.5% » 05:18
12/01/22
12/01
05:18
12/01/22
05:18
LI

Li Auto

$22.05 /

+3.51 (+18.93%)

Li Auto announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LI Li Auto
$22.05 /

+3.51 (+18.93%)

LI Li Auto
$22.05 /

+3.51 (+18.93%)

11/28/22 Jefferies
Li Auto initiated with a Buy at Jefferies
11/25/22 DBS Bank
Li Auto initiated with a Buy at DBS Bank
10/28/22 Barclays
Li Auto price target lowered to $25 from $40 at Barclays
09/06/22 Morgan Stanley
September 'crunch time' for China EV makers, says Morgan Stanley
LI Li Auto
$22.05 /

+3.51 (+18.93%)

LI Li Auto
$22.05 /

+3.51 (+18.93%)

LI Li Auto
$22.05 /

+3.51 (+18.93%)

LI Li Auto
$22.05 /

+3.51 (+18.93%)

Downgrade
Wolters Kluwer downgraded to Underperform from Neutral at Exane BNP Paribas » 05:18
12/01/22
12/01
05:18
12/01/22
05:18
WTKWY

Wolters Kluwer

$110.24 /

+2.47 (+2.29%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTKWY Wolters Kluwer
$110.24 /

+2.47 (+2.29%)

WTKWY Wolters Kluwer
$110.24 /

+2.47 (+2.29%)

11/03/22 UBS
Wolters Kluwer price target lowered to EUR 124 from EUR 130 at UBS
10/18/22 Morgan Stanley
Wolters Kluwer price target raised to EUR 126 from EUR 120 at Morgan Stanley
10/10/22 Credit Suisse
Wolters Kluwer price target raised to EUR 116 from EUR 115 at Credit Suisse
10/05/22 Deutsche Bank
Wolters Kluwer price target lowered to EUR 80 from EUR 85 at Deutsche Bank
Downgrade
Thomson Reuters downgraded to Underperform from Neutral at Exane BNP Paribas » 05:17
12/01/22
12/01
05:17
12/01/22
05:17
TRI

Thomson Reuters

$117.75 /

+4.22 (+3.72%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$117.75 /

+4.22 (+3.72%)

TRI Thomson Reuters
$117.75 /

+4.22 (+3.72%)

11/02/22 BMO Capital
Thomson Reuters price target raised to $165 from $160 at BMO Capital
08/05/22 Canaccord
Thomson Reuters price target raised to $122 from $115 at Canaccord
07/01/22 Barclays
Thomson Reuters price target lowered to $115 from $125 at Barclays
06/14/22 CIBC
Thomson Reuters upgraded to Outperformer from Neutral at CIBC
TRI Thomson Reuters
$117.75 /

+4.22 (+3.72%)

Hot Stocks
AbCellera, Rallybio enter pact for novel antibody-based therapeutics » 05:17
12/01/22
12/01
05:17
12/01/22
05:17
ABCL

AbCellera

$12.87 /

-0.5 (-3.74%)

, RLYB

Rallybio

$5.79 /

+0.19 (+3.39%)

AbCellera (ABCL) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABCL AbCellera
$12.87 /

-0.5 (-3.74%)

RLYB Rallybio
$5.79 /

+0.19 (+3.39%)

ABCL AbCellera
$12.87 /

-0.5 (-3.74%)

11/30/22 Piper Sandler
Bebtelovimab losing EUA has 'limited impact' on Piper model for AbCellera
11/16/22 Truist
AbCellera initiated with a Buy at Truist
11/01/22 Piper Sandler
AbCellera price target lowered to $21 from $22 at Piper Sandler
08/10/22 Credit Suisse
AbCellera price target lowered to $34 from $40 at Credit Suisse
RLYB Rallybio
$5.79 /

+0.19 (+3.39%)

02/22/22 JMP Securities
Rallybio initiated with an Outperform at JMP Securities
ABCL AbCellera
$12.87 /

-0.5 (-3.74%)

RLYB Rallybio
$5.79 /

+0.19 (+3.39%)

  • 11
    Nov
ABCL AbCellera
$12.87 /

-0.5 (-3.74%)

Downgrade
Pearson downgraded to Neutral from Outperform at Exane BNP Paribas » 05:17
12/01/22
12/01
05:17
12/01/22
05:17
PSO

Pearson

$12.01 /

+0.23 (+1.95%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSO Pearson
$12.01 /

+0.23 (+1.95%)

PSO Pearson
$12.01 /

+0.23 (+1.95%)

10/25/22 JPMorgan
Pearson price target lowered to 1,060 GBp from 1,080 GBp at JPMorgan
10/25/22 Societe Generale
Pearson price target raised to 1,140 GBp from 945 GBp at Societe Generale
10/05/22 Deutsche Bank
Pearson price target raised to 1,140 GBp from 900 GBp at Deutsche Bank
10/03/22 Credit Suisse
Pearson price target raised to 998 GBp from 975 GBp at Credit Suisse
PSO Pearson
$12.01 /

+0.23 (+1.95%)

PSO Pearson
$12.01 /

+0.23 (+1.95%)

Downgrade
Equinor downgraded to Hold from Buy at HSBC » 05:15
12/01/22
12/01
05:15
12/01/22
05:15
EQNR

Equinor

$38.49 /

+0.865 (+2.30%)

HSBC analyst Kim Fustier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQNR Equinor
$38.49 /

+0.865 (+2.30%)

EQNR Equinor
$38.49 /

+0.865 (+2.30%)

11/10/22 DNB Markets
Equinor downgraded to Hold from Buy at DNB Markets
11/08/22 Morgan Stanley
Equinor price target raised to NOK 342 from NOK 304 at Morgan Stanley
11/01/22 Societe Generale
Equinor price target raised to NOK 360 from NOK 345 at Societe Generale
11/01/22 UBS
Equinor price target lowered to NOK 370 from NOK 380 at UBS
EQNR Equinor
$38.49 /

+0.865 (+2.30%)

EQNR Equinor
$38.49 /

+0.865 (+2.30%)

EQNR Equinor
$38.49 /

+0.865 (+2.30%)

Downgrade
Eni SpA downgraded to Hold from Buy at HSBC » 05:13
12/01/22
12/01
05:13
12/01/22
05:13
E

Eni SpA

$29.68 /

+0.11 (+0.37%)

HSBC analyst Kim Fustier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
E Eni SpA
$29.68 /

+0.11 (+0.37%)

E Eni SpA
$29.68 /

+0.11 (+0.37%)

11/23/22 Barclays
Eni SpA reinstated with an Overweight at Barclays
11/08/22 Morgan Stanley
Eni SpA price target raised to EUR 15.80 from EUR 14.10 at Morgan Stanley
11/08/22 Exane BNP Paribas
Eni SpA reinstated with an Outperform at Exane BNP Paribas
09/26/22 JPMorgan
Eni SpA price target raised to EUR 19 from EUR 18.50 at JPMorgan
E Eni SpA
$29.68 /

+0.11 (+0.37%)

E Eni SpA
$29.68 /

+0.11 (+0.37%)

Hot Stocks
NIO Inc. delivers 14,178 vehicles in November, up 30.3% » 05:13
12/01/22
12/01
05:13
12/01/22
05:13
NIO

Nio

$12.77 /

+2.26 (+21.50%)

, TCEHY

Tencent

$37.79 /

+1.44 (+3.96%)

Nio (NIO) announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO Nio
$12.77 /

+2.26 (+21.50%)

TCEHY Tencent
$37.79 /

+1.44 (+3.96%)

NIO Nio
$12.77 /

+2.26 (+21.50%)

11/28/22 Jefferies
Nio assumed with a Hold at Jefferies
11/21/22 Deutsche Bank
'Worse may finally be over' for Nio, says Deutsche Bank
11/17/22 UBS
Nio downgraded to Neutral at UBS on expectations for ET5 execution challenges
11/17/22 UBS
Nio downgraded to Neutral from Buy at UBS
TCEHY Tencent
$37.79 /

+1.44 (+3.96%)

11/02/22 Morgan Stanley
Tencent named a 'Catalyst Driven Idea' at Morgan Stanley
10/28/22 Barclays
Tencent price target lowered to $31 from $44 at Barclays
10/24/22 KGI Securities
Tencent downgraded to Neutral from Outperform at KGI Securities
09/22/22 Stifel
Ubisoft downgraded to Hold from Buy at Stifel
NIO Nio
$12.77 /

+2.26 (+21.50%)

NIO Nio
$12.77 /

+2.26 (+21.50%)

TCEHY Tencent
$37.79 /

+1.44 (+3.96%)

NIO Nio
$12.77 /

+2.26 (+21.50%)

TCEHY Tencent
$37.79 /

+1.44 (+3.96%)

NIO Nio
$12.77 /

+2.26 (+21.50%)

Downgrade
Boliden downgraded to Sector Perform from Outperform at RBC Capital » 05:12
12/01/22
12/01
05:12
12/01/22
05:12
BDNNY

Boliden

$75.02 /

+2.815 (+3.90%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDNNY Boliden
$75.02 /

+2.815 (+3.90%)

BDNNY Boliden
$75.02 /

+2.815 (+3.90%)

11/18/22 Deutsche Bank
Boliden price target raised to SEK 350 from SEK 330 at Deutsche Bank
10/26/22 Morgan Stanley
Boliden price target lowered to SEK 325 from SEK 375 at Morgan Stanley
10/24/22 Berenberg
Boliden price target lowered to SEK 320 from SEK 340 at Berenberg
10/21/22 JPMorgan
Boliden price target lowered to SEK 305 from SEK 330 at JPMorgan
Downgrade
Anglo American downgraded to Sector Perform from Outperform at RBC Capital » 05:12
12/01/22
12/01
05:12
12/01/22
05:12
NGLOY

Anglo American

$20.50 /

+0.74 (+3.74%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

11/23/22 Deutsche Bank
Anglo American price target raised to 3,500 GBp from 3,400 GBp at Deutsche Bank
11/02/22 Morgan Stanley
Anglo American price target lowered to 3,160 GBp at Morgan Stanley
10/28/22 JPMorgan
Anglo American price target raised to 4,100 GBp from 4,000 GBp at JPMorgan
10/28/22 Credit Suisse
Anglo American price target lowered to 3,400 GBp at Credit Suisse
NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

Upgrade
SGS SA upgraded to Buy from Neutral at Citi » 05:09
12/01/22
12/01
05:09
12/01/22
05:09
SGSOY

SGS SA

$23.61 /

+0.74 (+3.24%)

Citi analyst Arthur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGSOY SGS SA
$23.61 /

+0.74 (+3.24%)

SGSOY SGS SA
$23.61 /

+0.74 (+3.24%)

11/25/22 Barclays
SGS SA downgraded to Underweight from Overweight at Barclays
11/21/22 JPMorgan
SGS SA downgraded to Underweight from Neutral at JPMorgan
11/17/22 Morgan Stanley
SGS SA price target lowered to CHF 2,220 from CHF 2,290 at Morgan Stanley
09/27/22 RBC Capital
SGS SA downgraded to Sector Perform from Outperform at RBC Capital
Hot Stocks
Xpeng delivers 5.811 Smart EVs in November » 05:08
12/01/22
12/01
05:08
12/01/22
05:08
XPEV

XPeng

$10.83 /

+3.48 (+47.35%)

XPeng announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
11/17/22 UBS
XPeng upgraded to Buy from Neutral at UBS
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

Upgrade
Cellnex Telecom upgraded to Buy from Neutral at UBS » 05:07
12/01/22
12/01
05:07
12/01/22
05:07
CLLNY

Cellnex Telecom

$17.25 /

+0.44 (+2.62%)

UBS analyst Ondrej…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLNY Cellnex Telecom
$17.25 /

+0.44 (+2.62%)

10/26/22 Jefferies
Cellnex Telecom price target lowered to EUR 40 from EUR 58 at Jefferies
10/17/22 JPMorgan
Cellnex Telecom price target lowered to EUR 54 from EUR 58 at JPMorgan
09/26/22 Barclays
Cellnex Telecom price target lowered to EUR 41 from EUR 66 at Barclays
08/22/22 JPMorgan
Cellnex Telecom price target lowered to EUR 58 from EUR 59 at JPMorgan
CLLNY Cellnex Telecom
$17.25 /

+0.44 (+2.62%)

Downgrade
Wartsila downgraded to Sector Perform from Outperform at RBC Capital » 05:05
12/01/22
12/01
05:05
12/01/22
05:05
WRTBY

Wartsila

$1.64 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$1.64 /

+ (+0.00%)

10/05/22 JPMorgan
Wartsila price target lowered to EUR 8.70 from EUR 9.20 at JPMorgan
10/03/22 Morgan Stanley
Wartsila assumed with an Equal Weight at Morgan Stanley
07/22/22 Citi
Wartsila price target raised to EUR 8.50 at Citi
04/29/22 UBS
Wartsila price target lowered to EUR 13.50 from EUR 15 at UBS
Initiation
International Distributions Services initiated with an Outperform at Exane » 05:03
12/01/22
12/01
05:03
12/01/22
05:03
ROYMY

International Distributions Services

$5.59 /

+0.0215 (+0.39%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROYMY International Distributions Services
$5.59 /

+0.0215 (+0.39%)

11/22/22 JPMorgan
International Distributions Services price target raised to 240 GBp from 190 GBp at JPMorgan
10/17/22 Barclays
International Distributions Services downgraded to Equal Weight at Barclays
09/30/22 Deutsche Bank
Royal Mail price target lowered to 144 GBp from 222 GBp at Deutsche Bank
09/16/22 JPMorgan
Royal Mail downgraded to Neutral from Overweight at JPMorgan
Upgrade
L'Oreal upgraded to Neutral from Sell at Citi » 05:01
12/01/22
12/01
05:01
12/01/22
05:01
LRLCY

L'Oreal

$74.41 /

+2.458 (+3.42%)

Citi analyst Cedric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

04:56 Today JPMorgan
L'Oreal downgraded to Neutral from Overweight at JPMorgan
10/25/22 Berenberg
L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg
10/24/22 Barclays
L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays
10/11/22 Morgan Stanley
L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

Upgrade
Essity upgraded to Neutral from Underweight at JPMorgan » 04:59
12/01/22
12/01
04:59
12/01/22
04:59
ETTYF

Essity

$22.85 /

-1.017 (-4.26%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETTYF Essity
$22.85 /

-1.017 (-4.26%)

11/22/22 Exane BNP Paribas
Essity upgraded to Outperform from Neutral at Exane BNP Paribas
11/01/22 Berenberg
Essity price target lowered to SEK 254 from SEK 266 at Berenberg
10/28/22 JPMorgan
Essity price target raised to SEK 220 from SEK 210 at JPMorgan
10/28/22 Credit Suisse
Essity price target lowered to SEK 286 from SEK 308 at Credit Suisse
Downgrade
Givaudan downgraded to Underweight from Neutral at JPMorgan » 04:59
12/01/22
12/01
04:59
12/01/22
04:59
GVDNY

Givaudan

$67.37 /

+1.7 (+2.59%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVDNY Givaudan
$67.37 /

+1.7 (+2.59%)

GVDNY Givaudan
$67.37 /

+1.7 (+2.59%)

10/13/22 Berenberg
Givaudan price target lowered to CHF 3,600 from CHF 3,800 at Berenberg
10/12/22 JPMorgan
Givaudan price target lowered to CHF 2,700 from CHF 3,300 at JPMorgan
10/12/22 Credit Suisse
Givaudan price target lowered to CHF 2,400 from CHF 2,900 at Credit Suisse
09/29/22 Citi
Givaudan upgraded to Buy from Neutral at Citi
Downgrade
Remy Cointreau downgraded to Underweight from Neutral at JPMorgan » 04:58
12/01/22
12/01
04:58
12/01/22
04:58
REMYY

Remy Cointreau

$17.26 /

+0.56 (+3.35%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$17.26 /

+0.56 (+3.35%)

10/26/22 Credit Suisse
Remy Cointreau price target lowered to EUR 155 from EUR 190 at Credit Suisse
10/26/22 Barclays
Remy Cointreau price target lowered to EUR 257 from EUR 325 at Barclays
10/12/22 Morgan Stanley
Remy Cointreau price target lowered to EUR 155 from EUR 160 at Morgan Stanley
09/12/22 Deutsche Bank
Remy Cointreau price target raised to EUR 310 from EUR 304 at Deutsche Bank
Downgrade
Davide Campari-Milano downgraded to Neutral from Overweight at JPMorgan » 04:57
12/01/22
12/01
04:57
12/01/22
04:57
DVDCF

Davide Campari-Milano

$10.90 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$10.90 /

+ (+0.00%)

11/08/22 Morgan Stanley
Davide Campari-Milano price target lowered to EUR 9.30 at Morgan Stanley
11/02/22 Societe Generale
Davide Campari-Milano price target lowered to EUR 12 at Societe Generale
11/01/22 Credit Suisse
Davide Campari-Milano price target lowered to EUR 10 from EUR 11.90 at Credit Suisse
11/01/22 Deutsche Bank
Davide Campari-Milano upgraded to Buy from Hold at Deutsche Bank
Downgrade
L'Oreal downgraded to Neutral from Overweight at JPMorgan » 04:56
12/01/22
12/01
04:56
12/01/22
04:56
LRLCY

L'Oreal

$74.41 /

+2.458 (+3.42%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

10/25/22 Berenberg
L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg
10/24/22 Barclays
L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays
10/11/22 Morgan Stanley
L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley
10/11/22 Deutsche Bank
L'Oreal price target lowered to EUR 380 from EUR 400 at Deutsche Bank
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

Conference/Events
Senate Agriculture, Nutrition & Forrestry Committee to hold a hearing » 04:55
12/01/22
12/01
04:55
12/01/22
04:55

The Committee holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS semiconductor analyst to hold an analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ADI

Analog Devices

$171.83 /

+7.89 (+4.81%)

Semiconductors Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

11/23/22 Deutsche Bank
Analog Devices price target raised to $170 from $155 at Deutsche Bank
11/23/22 Evercore ISI
Analog Devices price target raised to $195 from $185 at Evercore ISI
11/23/22 Truist
Analog Devices price target raised to $214 from $209 at Truist
11/23/22 Cowen
Analog Devices price target raised to $190 from $180 at Cowen
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

Conference/Events
Intellia Therapeutics to participate in a conference call with JPMorgan » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
NTLA

Intellia Therapeutics

$51.41 /

+3.44 (+7.17%)

SMid Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

11/14/22 Chardan
Intellia Therapeutics price target raised to $129 from $121 at Chardan
11/03/22 Chardan
Intellia Therapeutics price target lowered to $121 from $146 at Chardan
10/31/22 EF Hutton
Intellia Therapeutics initiated with a Buy at EF Hutton
10/11/22 Morgan Stanley
Intellia Therapeutics initiated with an Overweight at Morgan Stanley
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

  • 01
    Dec
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.